Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|December 23, 2025
Trends in Congenital Heart Disease Hospitalizations: What Nearly 50 Years of Longitudinal Data and Segmented Regression RevealSalma Pardhan, Hanna Gyllensten, Philip Moons, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 9, 2025
Factors associated with self-reported work ability among people with multiple sclerosis in SwedenFitsum Sebsibe Teni, Alejandra Machado, Jessica Dervish, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 20, 2024
Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in SwedenFitsum Sebsibe Teni, Alejandra Machado, Katharina Fink, et al.
European Journal of Clinical Pharmacology|September 27, 2015
Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based studyKhedidja Hedna, Katja M Hakkarainen, Hanna Gyllensten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Comparing Methods for Estimating Direct Costs of Adverse Drug EventsHanna Gyllensten, Anna K Jönsson, Katja M Hakkarainen, et al.
Antimicrobial Resistance and Infection Control|July 3, 2025
An economic evaluation of a hospital-wide bundle intervention to reduce hospital-acquired infections and bladder distension among hip fracture patients in SwedenSneha Abdul Jabbar, Maria Frödin, Ewa Wikström, et al.
Pharmacoeconomics - Open|June 13, 2019
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in SwedenKorinna Karampampa, Hanna Gyllensten, Fei Yang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 10, 2019
Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in SwedenHanna Gyllensten, Andrius Kavaliunas, Chantelle Murley, et al.
BMJ Open|June 25, 2013
Cost of illness of patient-reported adverse drug events: a population-based cross-sectional surveyHanna Gyllensten, Clas Rehnberg, Anna K Jönsson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 17, 2024
Health-related quality of life among older adults following acute hospitalization: longitudinal analysis of a randomized controlled trialEirin Guldsten Robinson, Hanna Gyllensten, Anne Gerd Granas, et al.
Pageof 9